Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × Plasma cell × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Completed 156 Recruiting 71 Terminated 70 Unknown 41 Active not recruiting 27 Not yet recruiting 13 Withdrawn 9 Suspended 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 CNS 4 Other solid neoplasm 3 Breast 3 Thoracic 2 Genitourinary 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 NET 1 Lymphoid 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Multiple Myeloma 1

Interventions

Lenalidomide 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

HuniLife Biotechnology, Inc.

Phase 1/2 Enrolling by invitation

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡